Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate
- Resource Type
- Authors
- Keira P. Mason; Bryan A. Max
- Source
- International Journal of Pediatrics
International Journal of Pediatrics, Vol 2010 (2010)
- Subject
- business.industry
Sedation
MEDLINE
lcsh:RJ1-570
Hemodynamics
lcsh:Pediatrics
Case Report
α2 adrenergic agonist
Anesthesia
Pediatrics, Perinatology and Child Health
Sedative Effects
Medicine
Dexmedetomidine
medicine.symptom
business
Extended infusion
medicine.drug
- Language
- English
- ISSN
- 1687-9759
1687-9740
Dexmedetomidine is an 2 adrenergic agonist which has recently been approved in the United States for procedural sedation in adults. This report describes an infant who inadvertently received an intravenous infusion of dexmedetomidine at a rate which was 60 times greater than intended. We describe the hemodynamic, respiratory, and sedative effects of this overdose.